Sunday, September 29, 2024
HomeIndustriesBiotechnology

Biotechnology

Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib)

Puma Biotechnology, Inc. a biopharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) issued a Patent Term Extension Certificate for U.S....

Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it entered into...

Red Cell Forms Zephyr AI to Revolutionize Drug Discovery and Precision Medicine

Red Cell Partners (“Red Cell”), an investment and incubation firm that backs, builds, and scales technology-led companies in healthcare and defense, today announced the...

Vaccibody Becomes Nykode Therapeutics – a New Name and Identity to Signify a New Phase of Growth and Development

Nykode Therapeutics (formerly Vaccibody)  (Euronext Growth (Oslo): VACC (ticker will soon be changed)), a clinical-stage biopharmaceutical company dedicated to the discovery and development of...

Transgene and NEC Announce Positive Preliminary Data From Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine

Transgene a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and...
0FansLike
0FollowersFollow
spot_img

Hot Topics